Woodline Partners LP Mirum Pharmaceuticals, Inc. Transaction History
Woodline Partners LP
- $11 Billion
- Q3 2024
A detailed history of Woodline Partners LP transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 331,005 shares of MIRM stock, worth $15.3 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
331,005
Previous 203,720
62.48%
Holding current value
$15.3 Million
Previous $6.97 Million
85.34%
% of portfolio
0.12%
Previous 0.07%
Shares
9 transactions
Others Institutions Holding MIRM
# of Institutions
188Shares Held
53.9MCall Options Held
177KPut Options Held
80.3K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$304 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$207 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$159 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$150 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$142 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.7B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...